Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Stopped The study ended earlier than anticipated due to slow accrual.
Conditions
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
Interventions
- PROCEDURE: Biospecimen Collection
- OTHER: Electronic Health Record Review
Sponsor
University of Washington
Collaborators